跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 788 条关于
“Pitolisant HD”
全部
788
临床试验
548
药物
87
机构
1
资讯
152
去年
FDA Issues Refusal to File for Pitolisant in Idiopathic Hypersomnia Treatment
去年
Harmony Biosciences Reports Strong Q4 2024 Results, Outlines Pipeline Milestones for 2025
去年
Harmony Biosciences Reports Strong Q3 2024 Results and Pipeline Advancements
12个月前
Harmony Biosciences' ZYN002 Phase 3 Trial Fails to Meet Primary Endpoint in Fragile X Syndrome
9个月前
FDA Expands Pitolisant Label to Include Cataplexy Treatment in Pediatric Narcolepsy Patients
2个月前
Harmony Biosciences Reports Phase 1 Data for Orexin-2 Agonist BP-205, Reinforcing Best-in-Class Potential
去年
Long-Term Real-World Data Confirms Pitolisant Safety and Efficacy in Narcolepsy Patients
去年
Vabysmo Shows Superior CST Reduction Compared to Eylea HD in DME and nAMD: Meta-Analysis
9个月前
Harmony Biosciences Reports Positive Bioequivalence Results for Pitolisant GR Formulation, Plans 2026 NDA Submission
11个月前
Viatris Acquires Aculys Pharma, Gains Rights to CNS Therapies Pitolisant and Spydia in Japan
第 1 页,共 16 页
上一页
下一页